Factores de crecimiento derivados de plaquetas : del laboratorio a la aplicación clínica hemato-oncológica.
Titulo:

Factores de crecimiento derivados de plaquetas : del laboratorio a la aplicación clínica hemato-oncológica.
.

Guardado en:

Revista Colombiana de Hematología y Oncología

2256-2877

2256-2915

Lombana, Milton

ASOCIACION COLOMBIANA DE HEMATOLOGIA Y ONCOLOGIA

10.51643/22562915.149

3

2016-06-01

8

9

Colombia

editorial

Milton Lombana - 2016

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.

info:eu-repo/semantics/openAccess

http://purl.org/coar/access_right/c_abf2

id metarevistapublica_acho_revistacolombianadehematologiayoncologia_27_article_149
record_format ojs
spelling Factores de crecimiento derivados de plaquetas : del laboratorio a la aplicación clínica hemato-oncológica.
Platelet-derived growth factors : from laboratory to hemato-oncological clinical application.
Lombana, Milton
editorial
3
2
Núm. 2 , Año 2016 : Junio
Artículo de revista
Journal article
2016-06-01T00:00:00Z
2016-06-01T00:00:00Z
2016-06-01
application/pdf
Asociación Colombiana de Hematología y Oncología (ACHO)
Revista Colombiana de Hematología y Oncología
2256-2877
2256-2915
https://revista.acho.info/index.php/acho/article/view/149
10.51643/22562915.149
https://doi.org/10.51643/22562915.149
spa
https://creativecommons.org/licenses/by-nc-sa/4.0
Milton Lombana - 2016
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
8
9
Gimbrone MA Jr, Aster RH, Cotran RS, Corkery J, Jandl JH, Folkman J. Preservation of vascular integrity in organs perfused in vitro with a platelet-rich medium. Nature 1969;222(5188):33-6.
Michelson A. Platelets. 3rd ed. Elsevier; 2012.
Smadja DM, Bura A, Szymezak J, Blanchard A, Remones V, Azizi M, et al. Effect of clopidogrel on circulating biomarkers of angiogenesis and endothelial activation. J Cardiol. 2012;59(1):30-5.
Etulain J, Fondevila C, Negrotto S, Schattner M. Platelet-mediated angiogenesis is independent of VEGF and fully inhibited by aspirin. Br J Pharmacol. 2013;170(2):255-65.
Nilsson J, Volk-Jovinge S, Svensson J, Landou C, De Faire U, Hamsten A. Association between high levels of growth factors in plasma and progression of coronary atherosclerosis. J Intern Med. 1992;232(5):397-404.
Currie GA. Platelet-derived growth-factor requirements for in vitro proliferation of normal and malignant mesenchymal cells. Br J Cancer. 1981;43(3):335-43.
Liu C, Zhao W, Meng W, Zhao T, Chen Y, Ahokas RA, et al. Platelet-derived growth factor blockade on cardiac remodeling following infarction. Mol Cell Biochem. 2014;397(1-2):295-304.
Zhao W, Zhao T, Huang V, Chen Y, Ahokas RA, Sun Y. Plateletderived growth factor involvement in myocardial remodeling following infarction. J Mol Cell Cardiol. 2011;51(5):830-8.
Zymek P, Bujak M, Chatila K, Cieslak A, Thakker G, Entman ML, et al. The role of platelet-derived growth factor signaling in healing myocardial infarcts. J Am Coll Cardiol. 2006;48(11):2315-23.
Yu J, Ustach C, Kim HR. Platelet-derived growth factor signaling and human cancer. J Biochem Mol Biol. 2003;36(1):49-59.
Wang Y, Appiah-Kubi K, Wu M, Yao X, Qian H, Wu Y, et al. The platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) are major players in oncogenesis, drug resistance, and attractive oncologic targets in cancer. Growth Factors. 2016;34(1-2):64-71.
Appiah-Kubi K, Wang Y, Qian H, Wu M, Yao X, Wu Y, et al. Platelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious therapeutic targets in cancers. Tumour Biol. 2016;37(8):10053-66.
Ehnman M, Östman A. Therapeutic targeting of platelet-derived growth factor receptors in solid tumors. Expert Opin Investig Drugs. 2014;23(2):211-26.
https://revista.acho.info/index.php/acho/article/download/149/125
info:eu-repo/semantics/article
http://purl.org/coar/resource_type/c_6501
http://purl.org/coar/resource_type/c_b239
http://purl.org/redcol/resource_type/ARTEDIT
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/version/c_970fb48d4fbd8a85
info:eu-repo/semantics/openAccess
http://purl.org/coar/access_right/c_abf2
Text
Publication
institution ASOCIACION COLOMBIANA DE HEMATOLOGIA Y ONCOLOGIA
thumbnail https://nuevo.metarevistas.org/ASOCIACIONCOLOMBIANADEHEMATOLOGIAYONCOLOGIA/logo.png
country_str Colombia
collection Revista Colombiana de Hematología y Oncología
title Factores de crecimiento derivados de plaquetas : del laboratorio a la aplicación clínica hemato-oncológica.
spellingShingle Factores de crecimiento derivados de plaquetas : del laboratorio a la aplicación clínica hemato-oncológica.
Lombana, Milton
editorial
title_short Factores de crecimiento derivados de plaquetas : del laboratorio a la aplicación clínica hemato-oncológica.
title_full Factores de crecimiento derivados de plaquetas : del laboratorio a la aplicación clínica hemato-oncológica.
title_fullStr Factores de crecimiento derivados de plaquetas : del laboratorio a la aplicación clínica hemato-oncológica.
title_full_unstemmed Factores de crecimiento derivados de plaquetas : del laboratorio a la aplicación clínica hemato-oncológica.
title_sort factores de crecimiento derivados de plaquetas : del laboratorio a la aplicación clínica hemato-oncológica.
title_eng Platelet-derived growth factors : from laboratory to hemato-oncological clinical application.
author Lombana, Milton
author_facet Lombana, Milton
topicspa_str_mv editorial
topic editorial
topic_facet editorial
citationvolume 3
citationissue 2
citationedition Núm. 2 , Año 2016 : Junio
publisher Asociación Colombiana de Hematología y Oncología (ACHO)
ispartofjournal Revista Colombiana de Hematología y Oncología
source https://revista.acho.info/index.php/acho/article/view/149
language spa
format Article
rights https://creativecommons.org/licenses/by-nc-sa/4.0
Milton Lombana - 2016
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
info:eu-repo/semantics/openAccess
http://purl.org/coar/access_right/c_abf2
references Gimbrone MA Jr, Aster RH, Cotran RS, Corkery J, Jandl JH, Folkman J. Preservation of vascular integrity in organs perfused in vitro with a platelet-rich medium. Nature 1969;222(5188):33-6.
Michelson A. Platelets. 3rd ed. Elsevier; 2012.
Smadja DM, Bura A, Szymezak J, Blanchard A, Remones V, Azizi M, et al. Effect of clopidogrel on circulating biomarkers of angiogenesis and endothelial activation. J Cardiol. 2012;59(1):30-5.
Etulain J, Fondevila C, Negrotto S, Schattner M. Platelet-mediated angiogenesis is independent of VEGF and fully inhibited by aspirin. Br J Pharmacol. 2013;170(2):255-65.
Nilsson J, Volk-Jovinge S, Svensson J, Landou C, De Faire U, Hamsten A. Association between high levels of growth factors in plasma and progression of coronary atherosclerosis. J Intern Med. 1992;232(5):397-404.
Currie GA. Platelet-derived growth-factor requirements for in vitro proliferation of normal and malignant mesenchymal cells. Br J Cancer. 1981;43(3):335-43.
Liu C, Zhao W, Meng W, Zhao T, Chen Y, Ahokas RA, et al. Platelet-derived growth factor blockade on cardiac remodeling following infarction. Mol Cell Biochem. 2014;397(1-2):295-304.
Zhao W, Zhao T, Huang V, Chen Y, Ahokas RA, Sun Y. Plateletderived growth factor involvement in myocardial remodeling following infarction. J Mol Cell Cardiol. 2011;51(5):830-8.
Zymek P, Bujak M, Chatila K, Cieslak A, Thakker G, Entman ML, et al. The role of platelet-derived growth factor signaling in healing myocardial infarcts. J Am Coll Cardiol. 2006;48(11):2315-23.
Yu J, Ustach C, Kim HR. Platelet-derived growth factor signaling and human cancer. J Biochem Mol Biol. 2003;36(1):49-59.
Wang Y, Appiah-Kubi K, Wu M, Yao X, Qian H, Wu Y, et al. The platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) are major players in oncogenesis, drug resistance, and attractive oncologic targets in cancer. Growth Factors. 2016;34(1-2):64-71.
Appiah-Kubi K, Wang Y, Qian H, Wu M, Yao X, Wu Y, et al. Platelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious therapeutic targets in cancers. Tumour Biol. 2016;37(8):10053-66.
Ehnman M, Östman A. Therapeutic targeting of platelet-derived growth factor receptors in solid tumors. Expert Opin Investig Drugs. 2014;23(2):211-26.
type_driver info:eu-repo/semantics/article
type_coar http://purl.org/coar/resource_type/c_6501
type_version info:eu-repo/semantics/publishedVersion
type_coarversion http://purl.org/coar/version/c_970fb48d4fbd8a85
type_content Text
publishDate 2016-06-01
date_accessioned 2016-06-01T00:00:00Z
date_available 2016-06-01T00:00:00Z
url https://revista.acho.info/index.php/acho/article/view/149
url_doi https://doi.org/10.51643/22562915.149
issn 2256-2877
eissn 2256-2915
doi 10.51643/22562915.149
citationstartpage 8
citationendpage 9
url2_str_mv https://revista.acho.info/index.php/acho/article/download/149/125
_version_ 1811200907756437504

Código QR

Estadísticas y Métricas Alternativas

Títulos similares